5 - Molecular Microbiology
References
- 1Molecular microbiology: diagnostic principles and practiceWashington DC (3rd ed.), ASM Press (2016)
- 2A new human immunodeficiency virus derived from gorillasNat Med, 15 (2009), pp. 871-872
- 3Performance of the Celera Diagnostics ViroSeq HIV-1 genotyping system for sequence-based analysis of diverse human immunodeficiency virus type 1 strainsJ Clin Microbiol, 42 (2004), pp. 2711-2717
- 4Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversionAnn Intern Med, 122 (1995), pp. 573-579
- 5Prognosis in HIV-1 infection predicted by the quantity of virus in plasmaScience, 272 (1996), pp. 1167-1170
- 6Prognostic value of HIV-1 RNA, CD4 cell count and CD4 cell count slope for progression to AIDS and death in untreated HIV-1 infectionJAMA, 297 (2007), pp. 2349-2350
- 7Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine and lamivudine. AIDS Clinical Trials Group Protocol 320Ann Intern Med, 135 (2001), pp. 954-964
- 8Suppression of plasma viral load below 20 copies/mL is required to achieve a long-term response to therapyAIDS, 12 (1998), pp. 1619-1624
- 9Prevalence and predictive value of intermittent viremia with combination HIV therapyJAMA, 286 (2001), pp. 171-179
- 10Acute human immunodeficiency virus type 1 infectionN Engl J Med, 339 (1998), pp. 33-39
- 11Centers for Disease Control and Prevention and Association of Public Health Laboratories. Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations. Available at: http://stacks.cdc.gov/view/cdc/23447; Published June 27, 2014.
- 12Kumar M, Setty HG, Hewlett IK. Point of care technologies of HIV. Hindawi Publishing Corporation, Volume 2014, Article ID 497046, 20 pages. https://doi.org/10.1155/2014/497046.
- 13High correlation between the Roche cobas(R) AmpliPrep/cobas(R) TaqMan(R) HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypesJ Clin Virol, 52 (2011), pp. 181-186
- 14HIV viral load markers in clinical practiceNat Med, 2 (1996), pp. 625-629
- 15Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1J Microbiol Methods, 69 (2007), pp. 384-386
- 16Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in plasma preparation tubes (PPT)J Clin Virol, 35 (2006), pp. 197-200
- 17Genetic organization and diversity of the hepatitis C virusProc Natl Acad Sci USA, 88 (1991), pp. 2451-2455
- 18Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypesVirology, 188 (1992), pp. 331-341
- 19Expanded classification of Hepatitis C virus into 7 genotypes and 67 subtypes: updated Criteria and Genotype assignment web resourceHepatology, 59 (2014), pp. 318-327
- 20Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and diseaseHepatology, 19 (1994), pp. 13-18
- 21Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosisHepatology, 25 (1997), pp. 211-215
- 22Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groupsLancet, 349 (1997), pp. 825-832
- 23Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic diseaseMMWR Recomm Rep, 47 (RR–19) (1998), pp. 1-39
- 24Diagnosis, management and treatment of hepatitis C: an updateHepatology, 49 (2009), pp. 1335-1374
- 25Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis and monitoringClin Chem, 46 (2000), pp. 2050-2068
- 26Guidelines for laboratory testing and result reporting of antibody to hepatitis C virusMMWR Recomm Rep, 52 (RR03) (2003), pp. 1-16
- 27Testing for HCV infection: an update of Guidance for Clinicians and LaboratoriansMMWR Recomm Rep, 62 (2013), pp. 362-365
- 28Natural fluctuations of hepatitis C viral load in a homogeneous patient population: a prospective studyHepatology, 31 (2000), pp. 225-229
- 29The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor StudyN Engl J Med, 334 (1996), pp. 1685-1690
- 30Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infectionTransfusion, 40 (2000), pp. 1192-1197
- 31Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assayJ Clin Microbiol, 40 (2002), pp. 1761-1766
- 32Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigenJ Clin Microbiol, 39 (2001), pp. 3110-3114
- 33Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replicationHepatology, 36 (2002), pp. 211-218
- 34Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapyJ Clin Microbiol, 41 (2003), pp. 3213-3220
- 35Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assayJ Clin Virol, 46 (2009), pp. 210-215
- 36A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigenJ Virol Methods, 157 (2009), pp. 8-14
- 37Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy GroupN Engl J Med, 339 (1998), pp. 1485-1492
- 38Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)Lancet, 352 (1998), pp. 1426-1432
- 39Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virusGastroenterology, 139 (2010), pp. 120-129
- 40An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic responseGastroenterology, 139 (2010), pp. 821-827
- 41Evaluation of liver histology, ALT elevation and HCV RNA titer in patients with chronic hepatitis CAm J Gastroenterol, 91 (1996), pp. 1516-1522
- 42An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver DiseasesHepatology, 54 (2011), pp. 1433-1444
- 43Sofosbuvir for previously untreated chronic hepatitis CN Engl J Med, 368 (2013), pp. 1878-1887
- 44Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 Hepatitic: the randomized PILLAR studyHepatology, 58 (2013), pp. 1918-1929
- 45The cobas AmpliPrep/cobas TaqMan HCV test, version 2.0, real-time PCR assay accurately quantifies hepatitis C virus genotype 4 RNAJ Clin Microbiol, 51 (2013), pp. 1078-1082
- 46Second-generation cobas AmpliPrep/cobas TaqMan HCV quantitative test for viral load monitoring: a novel dual-probe assay designJ Clin Microbiol, 51 (2013), pp. 571-577
- 47Establishment of the first international standard for nucleic acid amplification technology (NAT) assays for HCV RNA. WHO Collaborative Study GroupVox Sang, 76 (1999), pp. 149-158
- 48Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assayJ Clin Microbiol, 47 (2009), pp. 2872-2878
- 49Evaluation of the Abbott RealTime HCV assay for quantitative detection of hepatitis C virus RNAJ Clin Virol, 38 (2007), pp. 96-100
- 50Multicenter trials need to use the same assay for hepatitis C virus viral load determinationJ Clin Microbiol, 45 (2007), pp. 3788-3790
- 51Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevirGastroenterology, 132 (2007), pp. 1767-1777
- 52Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virusHepatology, 53 (2011), pp. 1742-1751
- 53Titusville NJ Reference ID 3412095(2013)
- 54A multicenter evaluation of the Abbott RealTime HCV Genotype II assayJ Virol Methods, 167 (2010), pp. 205-207
- 55Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0J Clin Microbiol, 46 (2008), pp. 1901-1906
- 56Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assayJ Clin Microbiol, 45 (2007), pp. 1140-1145
- 57Genetic heterogeneity of hepatitis C virus: quasispecies and genotypesSemin Liver Dis, 15 (1995), pp. 41-63
- 58Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 regionJ Gen Virol, 74 (1993), pp. 2391-2399
- 59Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis on the 5′ noncoding regionJ Clin Microbiol, 41 (2003), pp. 1558-1564
- 60Genotyping of hepatitis C virus isolates using CLIP sequencingJ Clin Microbiol, 38 (2000), pp. 3581-3584
- 61Hepatitis C virus genotyping based on 5′ noncoding sequence analysis (Trugene)J Clin Microbiol, 39 (2001), pp. 1771-1773
- 62A natural intergenotypic recombinant of hepatitis C virus identified in St. PetersburgJ Virol, 76 (2002), pp. 4034-4043
- 63Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virusJ Virol, 80 (2006), pp. 7569-7577
- 64New natural intergenotypic (2/5) recombinant of hepatitis C virusJ Virol, 81 (2007), pp. 4357-4362
- 65Recombinant hepatitis C virus in experimentally infected chimpanzeesJ Gen Virol, 88 (2007), pp. 143-147
- 66Validation of a solid-phase electrochemical array for genotyping hepatitis C virusExp Mol Pathol, 95 (2013), pp. 18-22
- 67Hepatitis B virus taxonomy and hepatitis B virus genotypesWorld J Gastroenterol, 13 (2007), pp. 14-21
- 68Chronic viral hepatitis as a public health issue in the worldBest Pract Res Clin Gastroenterol, 22 (2008), pp. 991-1008
- 69Hepatitis B virus infection—natural history and clinical consequencesN Engl J Med, 350 (2004), pp. 1118-1129
- 70Epidemiology and natural history of hepatitis B.Semin Liver Dis, 25 (Suppl. 1) (2005), pp. 3-8
- 71J. Versalovic, et al. (Eds.), Manual of clinical microbiology (10th ed), ASM Press, Washington DC (2011)
- 72Hepatitis B virus genotypes in the United States: results of a nationwide studyGastroenterology, 125 (2003), pp. 444-451
- 73Chronic hepatitis B: update 2009Hepatology, 50 (2009), pp. 661-662
- 74New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methodsMol Diagn Ther, 10 (2006), pp. 77-91
- 75Vaccine-induced escape mutant of hepatitis B virusLancet, 336 (1990), pp. 325-329
- 76Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxisHepatology, 26 (1997), pp. 786-791
- 77Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patientsHepatology, 15 (1992), pp. 757-766
- 78Molecular Detection and Characterization of Hepatitis B virusD.H. Persing, et al. (Eds.), Molecular microbiology: diagnostic principles and practice (2nd ed), ASM Press, Washington DC (2001), p. 583
- 79Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigenJ Virol, 68 (1994), pp. 8102-8110
- 80Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infectionLancet, 2 (1989), pp. 588-591
- 81The molecular basis of hepatitis B e antigen (HBeAg)-negative infectionsJ Viral Hepat, 4 (1997), pp. 1-8
- 82Indications for therapy in hepatitis BHepatology, 49 (2009), pp. S129-S137
- 83Monitoring during and after antiviral therapy for hepatitis BHepatology, 49 (2009), pp. S166-S173
- 84An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniquesVox Sang, 80 (2001), pp. 63-71
- 85Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variantsJ Clin Microbiol, 41 (2003), pp. 3699-3705
- 86Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotypeJ Clin Microbiol, 41 (2003), pp. 5473-5477
- 87Evaluation of the MagNA Pure LC used with the TRUGENE HBV Genotyping KitJ Clin Virol, 34 (2005), pp. 155-157
- 88Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantationJ Infect Dis, 176 (1997), pp. 1484-1490
- 89Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipientsTransplantation, 68 (1999), pp. 1305-1311
- 90Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized studyAntivir Ther, 12 (2007), pp. 63-72
- 91Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipientsBone Marrow Transplant, 41 (2008), pp. 873-879
- 92Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipientsJ Clin Microbiol, 38 (2000), pp. 2122-2127
- 93Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assaysJ Clin Microbiol, 40 (2002), pp. 1581-1586
- 94Cytomegalovirus (CMV) viral load kinetics to predict recurrent disease in solid organ transplant patients with CMV diseaseJ Infect Dis, 186 (2002), pp. 829-833
- 95Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patientsJ Clin Invest, 101 (1998), pp. 497-502
- 96Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysisJ Clin Microbiol, 50 (2012), pp. 337-345
- 97Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorderClin Transplant, 26 (2012), pp. 741-747
- 98Identifying the patient at risk for post-transplant lymphoproliferative disorderTranspl Infect Dis, 3 (2001), pp. 70-78
- 99Quantification of Epstein-Barr virus-DNA load in lung transplant recipients: a comparison of plasma versus whole bloodJ Heart Lung Transplant, 27 (2008), pp. 7-10
- 100Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reactionScand J Infect Dis, 39 (2007), pp. 235-244
- 101Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative diseaseJ Med Virol, 80 (2008), pp. 441-454
- 102Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipientsPediatr Transplant, 12 (2008), pp. 778-784
- 103Epstein-Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipientsClin Infect Dis, 45 (2007), pp. 1305-1309
- 104The impact of monitoring Epstein-Barr virus PCR in pediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?Pediatr Blood Cancer, 47 (2006), pp. 200-205
- 105Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in childrenAm J Transplant, 8 (2008), pp. 442-445
- 106Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipientsPediatr Transplant, 13 (2009), pp. 319-323
- 107Laboratory assays for Epstein-Barr virus-related diseaseJ Mol Diagn, 10 (2008), pp. 279-292
- 108Using Epstein-Barr viral load assays to diagnose, monitor and prevent posttransplant lymphoproliferative disorderClin Microbiol Rev, 23 (2010), pp. 350-366
- 109The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsilsJ Med Virol, 10 (1982), pp. 91-99
- 110BK virus: a clinical reviewClin Infect Dis, 33 (2001), pp. 191-202
- 111Lancet Infect Dis, 3 (2003), pp. 611-623
- 112Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complicationsTransplantation, 56 (1993), pp. 875-879
- 113Hemorrhagic cystitis in bone marrow transplantationUrology, 44 (1994), pp. 322-328
- 114Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted childrenPediatr Transplant, 2 (1998), pp. 288-293
- 115Association between polyomaviruria and microscopic haematuria in bone marrow transplant recipientsJ Infect, 29 (1994), pp. 139-146
- 116Human polyomavirus: lack of relationship of viruria to prolonged or severe hemorrhagic cystitis after bone marrow transplantBone Marrow Transplant, 4 (1989), pp. 279-282
- 117Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantationBlood, 98 (2001), pp. 1971-1978
- 118BK virus (BKV) quantification in urine samples of bone marrow transplanted patients is helpful for diagnosis of hemorrhagic cystitis, although wide individual variations existJ Clin Virol, 26 (2003), pp. 71-77
- 119New human papovavirus (B.K.) isolated from urine after renal transplantationLancet, 1 (1971), pp. 1253-1257
- 120BK virus infection in a kidney allograft diagnosed by needle biopsyAm J Kidney Dis, 26 (1995), pp. 671-673
- 121Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendationsTransplantation, 79 (2005), pp. 1277-1286
- 122Clinical course of polyoma virus nephropathy in 67 renal transplant patientsJ Am Soc Nephrol, 13 (2002), pp. 2145-2151
- 123Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytologyAm J Transplant, 1 (2001), pp. 373-381
- 124A prospective longitudinal study of BK virus infection in 104 renal transplant recipientsAm J Transplant, 5 (2005), pp. 1926-1933
- 125Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urineTransplantation, 74 (2002), pp. 987-994
- 126BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant ProgramClin Transpl, 16 (2002), pp. 143-153
- 127Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patientsJ Clin Microbiol, 42 (2004), pp. 1176-1180
- 128Polyomavirus PCR monitoring in renal transplant recipients: detection in blood is associated with higher creatinine valuesTransplant Proc, 33 (2001), pp. 1805-1807
- 129Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipientsN Engl J Med, 347 (2002), pp. 488-496
- 130Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipientsJ Infect Dis, 183 (2001), pp. 1669-1672
- 131Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathyN Engl J Med, 342 (2000), pp. 1309-1315
- 132Evolution of BK virus based on complete genome dataJ Mol Evol, 63 (2006), pp. 341-352
- 133Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assaysJ Clin Microbiol, 46 (2008), pp. 2671-2680
- 134Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United StatesSex Transm Dis, 26 (1996), pp. 339-344
- 135Chlamydia trachomatis infections of the adultK.K. Holmes, P.F. Sparling, P.-A. Mardh, et al. (Eds.), Sexually transmitted diseases (3rd ed), McGraw-Hill, New York (1999), pp. 407-422
- 136Nongonococcal urethritis-a new paradigmClin Infect Dis, 28 (1999), pp. S66-73
- 137International handbook of chlamydiaPolestar Wheatons Ltd, Exeter, UK (2001)
- 138The treatment of pelvic inflammatory diseaseAm J Obstet Gynecol, 138 (1980), pp. 1042-1047
- 139Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamdia trachomatisN Engl J Med, 310 (1984), pp. 545-549
- 140Gonorrhea. Med Clin North Am, 74 (1990), pp. 1353-1366
- 141Recommendations for the Laboratory-Based Detection of Chlamydia trachomatis and Neisseria gonorrhoeaeMMWR Recomm Rep, 63 (RR–2) (2014), pp. 1-19
- 142Intragenic variation by site-specific recombination in the cryptic plasmid of Neisseria gonorrhoeaeJ Bacteriol, 167 (1986), pp. 231-237
- 143A DNA sequence for the discrimination of Neisseria gonorrhoeas from other Neisseria speciesMol Cell Probes, 5 (1991), pp. 327-335
- 144Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections-2002MMWR Recomm Rep, 51 (RR–15) (2002), pp. 1-40
- 145High occurrence of a new variant of Chlamydia trachomatis escaping diagnostic tests among STI clinic patients in Stockholm, SwedenSex Transm Dis, 35 (2008), pp. 61-64
- 146PreservCyt transport medium used for the ThinPrep Pap test is a suitable medium for detection of Chlamydia trachomatis by the cobas Amplicor CT/NG test: results of a preliminary study and future implicationsJ Clin Microbiol, 40 (2002), pp. 1749-1754
- 147Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence EstimatesSex Transm Dis, 2013 (40) (2008), pp. 187-193
- 148Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture and polymerase chain reaction for diagnosis of trichomoniasis in men and womenAm J Obstet Gynecol, 200 (2009), p. 188e1–7
- 149A comparative evaluation of the Papanicolaou test for the diagnosis of trichomoniasisSex Transm Dis, 30 (2003), pp. 694-699
- 150Evaluation of the OSOM Trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infectionJ Clin Microbiol, 46 (2008), pp. 3467-3469
- 151Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VP111 for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implicationsJ Clin Microbiol, 49 (2011), pp. 866-869
- 152Molecular testing for Trichomonas vaginalis in women: results from a prospective U. S. clinical trialJ Clin Microbiol, 49 (2011), pp. 4106-4111
- 153Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx Assay on the BD Viper SystemJ Clin Microbiol, 52 (2014), pp. 885-889
- 154Using evidence base on genital herpes: optimizing the use of diagnostic tests and information provisionSex Transm Infect, 78 (2002), pp. 160-165
- 155Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification testJ Clin Microbiol, 50 (2012), pp. 3466-3471
- 156A rapid and simple isothermal nucleic acid amplification test for detection of herpes simplex virus types 1 and 2J Clin Virol, 50 (2011), pp. 26-30
- 157Natural history of genital herpes simplex virus type 1 infectionSex Transm Dis, 30 (2003), pp. 174-177
- 158HSV type specific serology in sexual health clinics: use, benefits, and who gets testedSex Transm Dis, 80 (2004), pp. 113-117
- 159Natural history of cervicovaginal papillomavirus infection in young womenN Engl J Med, 338 (1998), pp. 423-428
- 160American Cancer Society, American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerCA Cancer J Clin, 62 (2012), pp. 147-172
- 161The ATHENA human papillomavirus study: design, methods, and baseline resultsAm J Obstet Gynecol, 206 (2012), p. 46e1–11
- 162Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceGynecol Oncol, 136 (2012), pp. 178-182
- 163Cervical cancer screeing should be done by primary HPV testing with genotyping and reflex cytology for women over the age of 25 yearsJ Clin Microbiol (2015), 10.1128/JCM.01087-15[Epub ahead of print]
- 164Human papillomavirus genotype specificity of hybrid capture 2J Clin Microbiol, 46 (2008), pp. 2595-2604
- 165Clinical experience with the Cervista HPV HR assay: correlation of cervical cytology and HPV status from 56,501 specimensJ Mol Diagn, 13 (2011), pp. 160-166
- 166Patient safety and the next generation of HPV DNA testsAm J Clin Pathol, 134 (2010), pp. 193-199
- 167Comparison of the Aptima and Cervista tests for detection of high-risk human papillomavirus in cervical cytology specimensAm J Clin Pathol (2014), pp. 561-566
- 168Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer?Int J Cancer, 64 (1995), pp. 211-215
- 169The next influenza pandemic: lessons from Hong KongEmerg Infect Dis, 1999 (5) (1997), pp. 195-203
- 170Novel coronavirus and severe acute respiratory syndromeLancet, 361 (2003), pp. 1312-1313
- 171Comparison of a commercial qualitative real-time RT-PCR kit with direct immunofluorescence assay (DFA) and cell culture for detection of influenza A and B in childrenJ Clin Virol, 42 (2008), pp. 190-193
- 172Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in childrenJ Clin Microbiol, 44 (2006), pp. 2382-2388
- 173Evaluation of the one-step multiplex real-time reverse transcription-PCR ProFlu-1 assay for detection of influenza A and influenza B viruses and respiratory syncytial viruses in childrenJ Clin Microbiol, 46 (2008), pp. 789-791
- 174Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in childrenJ Infect Dis, 189 (2004), pp. 706-710
- 175Comparison of Biofire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1 and Luminex RVP Fast multiplex assays for detection of respiratory virusesJ Clin Microbiol, 51 (2013), pp. 1528-1533
- 176FilmArray, an automated nested multiplex PCR system for multipathogen detection: development and application to respiratory tract infectionPLoS ONE, 6 (2011), p. e26047
- 177Electrochemical detection-based DNA microarraysIVD Technol, 14 (2008), pp. 31-38
- 178Comparison of the GenMark Diagnostics eSensor Respiratory Viral Panel to real-time PCR for detection of respiratory viruses in childrenJ Clin Microbiol, 50 (2012), pp. 3458-3465
- 179Comparative evaluation of the Nanosphere Veirgene RV+ assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial virusesJ Clin Microbiol, 51 (2013), pp. 352-353
- 180Evaluation of the Alere i Influenza A&B nucleic acid amplification test by use of respiratory specimens collected in viral transport mediumJ Clin Microbiol, 52 (2014), pp. 3992-3995
- 181Tuberculosis morbidity—United StatesMMWR Recomm Rep, 1998 (47) (1997), pp. 253-257
- 182National plan for reliable tuberculosis laboratory services using a systems approach: recommendations from CDC and the Association of Public Health Laboratories Task Force on Tuberculosis Laboratory ServicesMMWR Recomm Rep, 54 (RR–6) (2005), pp. 1-12
- 183Diagnostic standards and classification of tuberculosis in adults and childrenAm J Respir Crit Care Med, 161 (2000), pp. 1376-1395
- 184Reduction in turnaround time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification testDiagn Microbiol Infect Dis, 52 (2005), pp. 247-254
- 185Use of the Amplified Mycobacterium tuberculosis Direct Test in a public health laboratory: test performance and impact on clinical careChest, 132 (2007), pp. 946-951
- 186A systematic review of rapid diagnostic tests for the detection of tuberculosis infectionHealth Technol Assess, 11 (2007), pp. 1-196
- 187In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regressionBMC Microbiol, 5 (2005), p. 55
- 188Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosisMMWR Recomm Rep, 58 (2009), pp. 7-10
- 189The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United StatesClin Infect Dis (2013), pp. 57532-57542
- 190Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use-United StatesMMWR Recomm Rep, 2013 (62) (2013), pp. 821-824
- 191Sunnyvale CA: Cepheid(2013)
- 192Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspeciesClin Microbiol Rev, 18 (2005), pp. 326-382
- 193Human infections associated with Bordetella bronchisepticaClin Microbiol Rev, 4 (1991), pp. 243-255
- 194Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptomsEmerg Infect Dis, 5 (1999), pp. 441-443
- 195Towards improved accuracy of Bordetella pertussis nucleic acid amplification testsJ Clin Microbiol, 50 (2012), pp. 2186-2190
- 196Identification and evaluation of new targets for specific detection of Bordetella pertussis by real-time PCRJ Clin Microbiol, 46 (2008), pp. 3228-3231
- 197Pertussis pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA from clinic surfacesPediatrics, 129 (2012), p. e424
- 198Diagnostic assays for identification of microorganisms and antimicrobial resistance determinants directly from positive blood culture brothClin Lab Med, 33 (2013), pp. 651-684
- 199Direct bacterial identification in positive blood cultures by use of two commercial matrix-assisted laser desorption ionization-time of flight mass spectrometry systemsJ Clin Microbiol, 51 (2013), pp. 1733-1739
- 200An introduction to peptide nucleic acidCurr Issues Mol Biol, 1 (1999), pp. 89-104
- 201Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood culturesJ Clin Microbiol, 45 (2007), pp. 191-196
- 202Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assaysJ Clin Microbiol, 47 (2009), pp. 823-826
- 203Multiplex identification of gram-positive bacteria and resistance determinants directly from positive blood culture broths: evaluation of an automated microarray-based nucleic acid testPLoS Med, 10 (2013), p. e1001478
- 204Identification of gram-negative bacteria and genetic resistance determinants from positive blood culture broths using Verigene gram-negative blood culture multiplex microarray-based molecular assayJ Clin Microbiol (2015), 10.1128/JCM.00581-15[Epub ahead of print]
- 205Clinical evaluation of the FilmArray blood culture identification panel in identification of bacteria and yeast from positive blood culture bottlesJ Clin Microbiol, 51 (2013), pp. 4130-4136
- 206Review of rapid diagnostic tests used by antimicrobial stewardship programsClin Infect Dis, 59 (2014), pp. S134-S145
- 207A multiplex real-time PCR assay for detection and differentiation of 25 bacterial and fungal pathogens from whole bloodMed Microbiol Immunol, 197 (2008), pp. 313-324
- 208Evaluation of a commercial multiplex PCR test (SeptiFast) in the etiological diagnosis of community-onset bloodstream infectionsEur J Clin Microbiol Infect Dis, 30 (2011), pp. 1127-1134
- 209Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsisJ Clin Microbiol, 49 (2011), pp. 2252-2258
- 210LightCycler Septifast technology in patients with solid malignancies: clinical utility for rapid etiologic diagnosis of sepsisCrit Care, 16 (2012), pp. 404-406
- 211Multiplex PCR for rapid and improved diagnosis of bloodstream infections in liver transplant recipientsJ Clin Microbiol, 50 (2012), pp. 2069-2071
- 212Ibis T5000: universal biosensor approach for microbiologyNat Rev Microbiol, 6 (2008), pp. 553-558
- 213PCR-electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratoriesJ Mol Diagn, 14 (2012), pp. 295-304
- 214Improved sensitivity for molecular detection of bacterial and Candida infections in bloodJ Clin Microbiol, 52 (2014), pp. 3164-3174
- 215T2 magnetic resonance enables nanoparticle-mediated detection of candidemia in whole bloodSci Transl Med, 5 (2013)182ra54
- 216T2 magnetic resonance assay for rapid diagnosis of candidemia in whole blood: a clinical trialClin Infect Dis, 60 (2015), pp. 892-896
- 217Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerationsClin Infect Dis, 20 (1995), pp. 414-420
- 218Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitisAnn Intern Med, 121 (1994), pp. 334-338
- 219Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluidLancet, 337 (1991), pp. 189-192
- 220Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupJ Infect Dis, 171 (1995), p. 857
- 221Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study GroupJ Infect Dis, 174 (1996), pp. 1162-1167
- 222Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serumArch Dis Child Fetal Neonatal Ed, 81 (1999), pp. F24-F29
- 223Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reactionClin Infect Dis, 20 (1995), pp. 842-848
- 224The clinical relevance of “CSF viral culture”: a two-year experience with aseptic meningitis in Rochester, NYJAMA, 247 (1982), pp. 1843-1847
- 225Diagnosis of enteroviral meningitis with the polymerase chain reactionJ Pediatr, 117 (1990), pp. 85-89
- 226New PCR test that recognizes all human prototypes of enterovirus: application for clinical diagnosisJ Clin Microbiol, 41 (2003), pp. 1750-1752
- 227Evaluation of a rapid real-time RT-PCR assay for detection of enterovirus RNA in cerebrospinal fluid specimensJ Clin Virol, 25 (2002), pp. S39-43
- 228Multicenter beta trial of the GeneXpert enterovirus assayJ Clin Microbiol, 45 (2007), pp. 1081-1086
- 229Clinical utility of polymerase chain reaction testing for enteroviral meningitisPediatr Infect Dis J, 18 (1999), pp. 533-538
- 230Cost analysis of enteroviral polymerase chain reaction in infants with fever and cerebrospinal fluid pleocytosisArch Pediatr Adolesc Med, 154 (2000), pp. 817-821
- 231Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient managementJAMA, 283 (2000), pp. 2680-2685
- 232Recent insights into Clostridium difficile pathogenesisCurr Opin Infect Dis, 26 (2013), p. 44753
- 233An epidemic, toxin gene-variant strain of Clostridium difficileN Engl J Med, 353 (2005), pp. 2433-2441
- 234Clostridium difficile testing: after 20 years, still challengingJ Clin Microbiol, 41 (2003), pp. 531-534
- 235Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxinJ Clin Microbiol, 44 (2006), pp. 1145-1149
- 236What is the role of algorithmic approaches for diagnosis of Clostridium difficile infection?J Clin Microbiol, 48 (2011), pp. 4347-4353
- 237Foodborne illness acquired in the United States-unspecified agentsEmerg Infect Dis, 17 (2011), pp. 16-22
- 238A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)Clin Infect Dis, 57 (2013), pp. e22-121
- 239A current overview of commercially available nucleic acid diagnostic approaches to detect and identify human gastroenteritis pathogensBiomol Detect Quantif, 1 (2014), pp. 2-7
- 240Clinical evaluation of a real-time PCR assay for identification of Salmonella, Shigella, Campylobacter (Campylobacter jejuni and C. coli) and Shiga toxin-producing E. coli isolates in stool specimensJ Clin Microbiol, 51 (2013), pp. 4001-4007
- 241Multicenter evaluation of the BD Max enteric panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga toxin 1 and 2 genesJ Clin Microbiol, 53 (2015), pp. 1639-1647
- 242Evaluation of Luminex xTAG gastrointestinal panel analyte-specific reagents for high-throughput, simultaneous detection of bacteria, viruses, and parasites of clinical and public health importanceJ Clin Microbiol, 51 (2013), pp. 3018-3024
- 243Novak SM, Bobenchik A, Cumpio J, et al. Evaluation of the Verigene EP IUO test for rapid detection of bacterial and viral causes of gastrointestinal infection. Abstract 1317 30th Clin Virol Symp Annu Meet Pan Am Soc Clin Virol.
- 244Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritisJ Clin Microbiol, 53 (2015), pp. 915-925
- 245New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from speciments containing a mixture of staphylococciJ Clin Microbiol, 42 (2004), pp. 1875-1884
- 246Correlation of penicillin binding protein 2a detection with oxacillin resistance in Staphylococcus aureus and discovery of a novel penicillin binding protein 2a mutationJ Clin Microbiol (2005), pp. 434541-434544
- 247Characterization of Staphylococcus aureus isolates with a partial or complete absence of staphylococcal cassette chromosome elementsJ Clin Microbiol, 48 (2010), pp. 3525-3531
- 248Rapid diagnostics for methicillin-resistant Staphylococcus aureus: current statusMol Diagn Ther, 12 (2008), pp. 15-24
- 249Effect on MRSA transmission of rapid testing of patients admitted to critical careJ Hosp Infect, 65 (2007), pp. 24-28
- 250Universal surveillance of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitalsAnn Intern Med, 148 (2008), pp. 409-418
- 251Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a perspective multicenter trialAnn Intern Med, 135 (2001), pp. 484-492
- 252Recommendations for preventing spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HIC-PAC)MMWR Recomm Rep, 44 (1995), pp. 1-13
- 253Detection of vancomycin-resistant enterococci in fecal samplesJ Clin Microbiol, 35 (1997), pp. 2325-2330
- 254Comparison of PCR assay to culture for surveillance detection of vancomycin-resistant enterococciJ Clin Microbiol (2003), pp. 4805-4807
- 255Identification and screening of carbapenemase-producing EnterobacteriaceaeClin Microbiol Infect, 18 (2012), pp. 432-438
- 256Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?J Antimicrob Chemother, 67 (2012), pp. 1569-1577
- 257Development and evaluation of a real-time PCR assay for detection of Klebsiella pneumoniae carbapenemase genesJ Clin Microbiol, 47 (2009), pp. 322-326
- 258Evaluation of a DNA microarray, the Check-Points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and KPC carbapenemasesAntimicrob Agents Chemother, 54 (2010), pp. 3086-3092
- 259Evaluation of a DNA microarray for the rapid detection of extended-spectrum beta-lactamases (TEM, SHV, and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR, and CMY-1-like/MOX) and carbapenemases ( KPC, OXA-48, VIM, IMP, and NDM)J Antimicrob Chemother, 67 (2012), pp. 1865-1869
- 260The cost-effectiveness of ESBL detection: towards molecular detection methods?Clin Microbiol Infect, 19 (2012), pp. 662-665
- 261Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCRJ Clin Microbiol, 50 (2012), pp. 3115-3118
- 262Evaluation of the new NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC)J Clin Microbiol, 50 (2012), pp. 2783-2785
- 263The human microbiome: at the interface of health and diseaseNat Rev Genet, 13 (2012), pp. 260-270
- 264Emerging view of the human viromeTransl Res, 160 (2012), pp. 283-290
- 265Metagenomic pyrosequencing and microbial identificationClin Chem, 55 (2009), pp. 856-866
- 266Evaluation of 16S rDNA-based community profiling for human microbiome researchPLoS ONE (2012), p. 7e39315
- 267A framework for human microbiome researchNature, 486 (2012), pp. 215-221
- 268Structure function and diversity of the healthy human microbiomeNature, 486 (2012), pp. 207-214
- 269A core human microbiome as viewed through 16S rRNA sequence clustersPLoS ONE, 7 (2012), p. e34242
- 270Metabolic reconstruction for metagenomics data and its application to the human microbiomePLoS Comput Biol, 8 (2012), p. e1002358
- 271Complex carbohydrate utilization by the healthy human microbiomePLoS ONE, 7 (2012), p. e28742
- 272Fixing the microbiota to treat Clostridium difficile infectionsNat Med, 20 (2014), pp. 246-247
- 273Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCRJ Virol Methods, 186 (2012), pp. 68-72
- 274Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirusJ Clin Microbiol, 51 (2013), pp. 540-546
- 275Point-of-care nucleic acid testing for infectious diseasesTrends Biotechnol, 29 (2011), pp. 240-250
- 276Whole-genome sequencing for outbreak investigations of methicillin resistant Staphylococcus aureus in the neonatal intensive care unit: time for routine practice?Infect Control Hosp Epidemiol, 36 (2015), pp. 777-785
- 277A culture-independent sequence-based metagenomics approach to investigation of an outbreak of shiga-toxigenic Escherichia coli O104:H4JAMA, 309 (2013), pp. 1502-1510
- 278Clonal integration of a polyomavirus in human Merkel cell carcinomaScience, 319 (2008), pp. 1096-1100
- 279Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic studyLancet, 382 (2013), pp. 1993-2002
- 280Substantial alterations of the cutaneous bacterial biota in psoriatic lesionsPLoS ONE, 3 (2008), p. e2719
- 281Helicobacter pylori and gastrointestinal tract adenocarcinomasNat Rev Cancer, 2 (2002), pp. 28-37
- 282Helicobacter pylori and esophageal cancer risk: a meta-analysisCancer Prev Res (Phila), 1 (2008), pp. 329-338
- 283An obesity-associated gut microbiome with increased capacity of energy harvestNature, 444 (2006), pp. 1027-1031
- 284Obestity alters gut microbial ecologyProc Natl Acad Sci USA, 102 (2005), pp. 11070-11075
- 285Inverse associations of Helicobacter pylori with asthma and allergyArch Intern Med, 167 (2007), pp. 821-827
- 286Does Helicobacter pylori protect against asthma and allergy?Gut, 57 (2008), pp. 561-567
- 287Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitisCell Host Microbe, 8 (2010), pp. 292-300
- 288Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndromeNeurogastroenterol Motil, 22 (2010), pp. 512-519
- 289Genomic analysis identifies association of Fusobacterium with colorectal carcinomaGenome Res, 22 (2012), pp. 292-298
- 290Fusobacterium nucleatum infection is prevalent in human colorectal carcinomaGenome Res, 22 (2012), pp. 299-306
- 291Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature (2011), pp. 47257-47263
Cited by (0)
- ∗
The author wishes to acknowledge the contributions of Aaron D. Bossler and Angela M. Caliendo who authored this chapter in the previous edition.
Copyright © 2018 Elsevier Inc. All rights reserved.